ZAFIRLUKAST (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the ZAFIRLUKAST drug offered from AstraZeneca Pharmaceuticals LP. This Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | Zafirlukast |
| SUBSTANCE NAME: | ZAFIRLUKAST |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-11-19 |
| END MARKETING DATE: | 2018-04-30 |
ZAFIRLUKAST HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZAFIRLUKAST from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2010-11-19 |
| END MARKETING DATE: | 2018-04-30 |
| PRODUCT ID: | 0310-0411_705f58d2-a75f-4683-9546-352a5a297e42 |
| PRODUCT NDC: | 0310-0411 |
| APPLICATION NUMBER: | NDA020547 |
Other ZAFIRLUKAST Pharmaceutical Manufacturers / Labelers:
